Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02488837 · ClinicalTrials.gov registry record

Investigation of Non-Invasive Outcomes Predictors in Patients Undergoing DBS for Movement Disorders

A clinical trial, sponsored by University of Alabama at Birmingham.

Completed
Registry status
21
Enrollment target

NCT02488837: Completed study, sponsored by University of Alabama at Birmingham.

NCT02488837 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02488837 has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
21 participants
Enrollment target

Study Summary

The purpose of the study is to determine if non-invasive measurements of brain waves from the skin called electroencephalography (EEG) can predict whether the brain stimulator will help your symptoms. Our goal is to obtain these brain wave measurements with patients both awake and under general anesthesia, and then to evaluate which brain wave patterns are associated with clinical improvement to determine if they could be useful for predicting whether the surgery will work. If such predictive measures were established based upon the findings of this study, they could be used in the future to improve surgical outcomes in the following ways: (1) to help guide surgical targeting in the operating room awake or under anesthesia, (2) to guide post-operative programming in clinic, and (3) and to develop potential feedback systems for "automatic" programming of the brain stimulator system at home.

Primary Outcome

Validated rating scale for measuring symptoms of Parkinson's disease

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2014-06
Est. Completion 2016-12-01
University of Alabama at Birmingham

1,160 total trials

What the finished NCT02488837 record still lists

NCT02488837 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02488837 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02488837 about?

NCT02488837 is a clinical study titled "Investigation of Non-Invasive Outcomes Predictors in Patients Undergoing DBS for Movement Disorders". The purpose of the study is to determine if non-invasive measurements of brain waves from the skin called electroencephalography (EEG) can predict whether the brain stimulator will help your symptoms. Our goal is to obtain these brain wave measurements with patients both awake and under general anes...

What is the current status of trial NCT02488837?

This trial is currently completed. The enrollment target is 21 participants. The study started on 2014-06. Estimated completion is 2016-12-01.

Who is sponsoring clinical trial NCT02488837?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02488837, the US trial registry maintained by the National Library of Medicine. NCT02488837 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.